Project Number GC-2013910 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2017 View Full Project Details for Evaluating the effects of the novel GLP-I analogue, liraglutide, in patients with Alzherimer's disease (ELAD Study) - Open Label Extension Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) j. Metabolism and Bioenergetics Researcher and Organization Principal Investigator Edison, Paul Principal Investigator First Name Paul Principal Investigator Last Name Edison Awardee Organization Imperial College of Science, Technology and Medicine (Imperial College London) Contact PI Country United Kingdom Project Detail Funding Opportunity Announcement PACT Program FY Overall Cost $340,540 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
